Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05061316 · ClinicalTrials.gov registry record · NA

The Gut Microbiome As an Indicator of Readiness for Head & Neck Cancer Surgery

A NA study of Cancer of Head and Neck and Nutrition Aspect of Cancer, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05061316 is a NA study of Cancer of Head and Neck and Nutrition Aspect of Cancer that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 20 participants, below the 247-participant average among 9 other Cancer of Head and Neck trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05061316, a NA study of Cancer of Head and Neck and Nutrition Aspect of Cancer, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to understand how a pre-operative nutritional intervention alters the gut microbiome and improves outcomes after major head and neck cancer surgery.

Interventions

  • DIETARY_SUPPLEMENT Nestlé Impact Advanced Recovery

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2022-03-11
Est. Completion 2025-02-01
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT05061316

The ClinicalTrials.gov registry entry for NCT05061316 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 247-participant average among 9 other Cancer of Head and Neck trials with a reported enrollment target (92% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cancer of Head and Neck appearing as the primary indexed condition, and to 1 intervention - of which Nestlé Impact Advanced Recovery is the first listed.

NCT05061316 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT05061316 about?

NCT05061316 is a clinical study titled "The Gut Microbiome As an Indicator of Readiness for Head & Neck Cancer Surgery". The purpose of this study is to understand how a pre-operative nutritional intervention alters the gut microbiome and improves outcomes after major head and neck cancer surgery.

What is the current status of trial NCT05061316?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2022-03-11. Estimated completion is 2025-02-01.

What conditions does trial NCT05061316 study?

This clinical trial studies the following conditions: Cancer of Head and Neck, Nutrition Aspect of Cancer.

What interventions are being tested in trial NCT05061316?

The interventions under investigation include: Nestlé Impact Advanced Recovery (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05061316?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05061316 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer of Head and Neck

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.